JAKAVI (ruxolitinib) | HCP
JAKAVI (ruxolitinib) for the treatment of myelofibrosis and for the treatment of polycythaemia vera in patients resistant to or intolerant of hydroxyurea.
Language: English
As the largest professionally led nonprofit network of cancer support worldwide, the Cancer Support Community is dedicated to ensuring that all people impacted by cancer are empowered by knowledge, strengthened by action, and sustained by community. We are a global nonprofit network of 190 CSC and Gilda's Club locations, including 52 licensed affiliates and healthcare partnerships that deliver free support and navigation services to patients and families.
Learn about Jakafi® (ruxolitinib) - Used to treat adults with polycythemia vera who have taken hydroxyurea and it did not work well enough or they could not tolerate it, and adults with certain types of myelofibrosis. Jakafi is used to treat adults and children 12 years of age and older with acute graft-versus-host disease (GVHD) who have taken corticosteroids and they did not work well enough. Jakafi is also used to treat adults and children 12 years of age and older with chronic GVHD who have taken one o
For more than 30 years, the MTSL (Medical Technology Stock Letter), published by BioInvest, has provided independent investment advice based on rigorous analysis of emerging biotechnology companies and a unique perspective on industry fundamentals. MTSL has a proven track record of identifying many of today's industry leaders well before the consensus of other analysts.
Incyte is a global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines..
-- By Zhenya Senyak Notes on MPN Mutations, is a description of 15 of the most common driving and passenger MPN mutations currently discovered. These are those genetic changes that create the proteins that play a role in the thrombosis, itching, inflammation and fatigue that characterize the myeloproflierative chaotic blood production system. The Almanac…
Read or watch tech news on Technology.Press release Distribution services is available for the Technology industry.
Information Technology News and Press release services for the IT industry.
Accell Clinical Research is an international full-service Contract Research Organization (CRO) managing Phase I-III clinical trials for 10+ years across Eastern Europe and post-Soviet countries.
The MF Challenge aims to discover the factors that induce fibrosis in bone marrow, and to identify opportunities to arrest and reverse this fibrosis.